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INTRODUCTION
During the past decade it has become clear that
in cells of higher organisms most protein synthesis
is mediated by polysomes occurring free in the
cytoplasm or attached to the endoplasmic reticu-
lum. There is ample evidence, however, that
synthesis of proteins may also occur at other loci
within the cell ; for example, in mitochondria (1-3),
in chloroplasts (4-6), and in the nucleus (7-11) .
Protein synthesis in both mitochondria and
chloroplasts differs from that occurring elsewhere
in the cytoplasm, resembling, rather, that of
bacterial systems . Thus, ribosomes from mito-
chondrial and chloroplasts, like those of bacteria,
are smaller than those from microsomal systems
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(3, 5), and the response of mitochondrial and
chloroplast protein-synthesizing systems to in-
hibitors of protein synthesis is similar to that of
bacterial, rather than of microsomal, systems
(2, 4, 6) .
Nuclear protein synthesis has generally been
found to resemble the predominant type of cyto-
plasmic protein synthesis (7, 8, 10). Several
workers, however, have described a chromatin-
catalyzed incorporation of amino acids into
polypeptide chains which differs from both bac-
terial and microsomal protein-synthesizing sys-
tems in many respects, including its response to
several antibiotics (12, 13).
To learn more about the role of the cell nucleus
in protein synthesis and to define more closely thenature of this synthesis, we have investigated the
effect of various inhibitors of protein and RNA
metabolism on the incorporation of labeled amino
acids into protein by the cell nucleus in vivo.
MATERIALS AND METHODS
Male Holtzman albino rats weighing 270-370 g were
used ; animals were fasted for 23-25 hr before ad-
ministration of the radioisotope . Inhibitors were in-
jected interperitoneally : actinomycin D, as a solution
in 33% propylene glycol-0 .10 M NaCl ; chlorampheni-
col, as a solution in 25 1 /,) propylene glycol-0.11 M
NaCl ; and all other inhibitors, as neutral solutions
in 0.15 M NaCI. At various times after administration
of the inhibitors, the animals were anesthetized with
ether and injected with 0 .16 ml per 100 g body
weight of a solution containing 407 µc (0 .081 µmoles)
of L-leucine-4,5- 3H per milliliter and unlabeled
amino acids and inorganic salts in the same concen-
trations as in previous studies (11).
Animals that had received actinomycin D and the
corresponding controls were given the isotope solu-
tion via the femoral vein ; in all other cases the iso-
tope was injected into the hepatic portal vein . 2 min
after injection of isotope, livers were rapidly frozen
in situ, excised, lyophilized, and separated into cyto-
plasmic and nuclear fractions in nonaqueous solvents
(11). The specific activities of the total nuclear and
cytoplasmic proteins were determined essentially as
described earlier (11) .
RESULTS AND DISCUSSION
The effect of actinomycin D, an inhibitor of
DNA-dependent RNA synthesis, of thioacetamide,
a drug which has been shown to interfere with the
metabolism of ribosomal precursor RNA (14),
and of several widely used inhibitors of protein
synthesis on the ability of rat liver nuclei and
cytoplasm to incorporate labeled amino acid into
protein has been studied. The results are presented
in Table I.
For those treatments in which repeat determina-
tions were run, the absolute level of incorporation
was found to vary greatly from one trial to the
next. This is not unexpected since the absolute
level of isotope incorporation attained after 2
min, the time employed in the present experi-
ments, is still very low, whereas the rate of incor-
poration is near its maximum value (11) . We
attach no significance, therefore, to moderate
differences in the absolute level of incorporation
between two treatments ; for example, between the
various thioacetamide treatments and the cor-
responding control. Much more significant is the
ratio of incorporation in the cytoplasm to in-
corporation in the nucleus, a value which, as might
be expected, is subject to much less variation than
the absolute levels of incorporation. A change in
this ratio as a result of a treatment with an inhibi-
tor would indicate that the inhibitor had affected
nuclear and cytoplasmic protein synthesis to
different degrees.
The following assumptions are implicit in our
interpretation of the above data : (a) no exchange
or preferential loss of protein occurs during isola-
tion of the nuclear and cytoplasmic fractions ; (b)
the concentration of labeled amino acid is the
same in the nucleus and the cytoplasm during the
labeling period; (c) movement of significant
amounts of protein between the nucleus and
cytoplasm does not occur during the labeling
period. Evidence for the validity of these assump-
tions has been presented in a previous paper (11) .
Except for puromycin, none of the inhibitors
tested showed a significant difference in its effect
on nuclear and cytoplasmic protein synthesis.
The difference in the ratio of cytoplasmic in-
corporation to nuclear incorporation between
the 25 mg/kg-20 m puromycin treatment and
the appropriate control is significant at the 2 %
level by the t-test. It should be noted that in puro-
mycin-treated animals the specific activity of the
total nuclear protein is higher than that of the
cytoplasmic protein, whereas in the control ani-
mals exactly the reverse is true . Because of its
ability to reverse the relative level of cytoplasmic
to nuclear incorporation, puromycin promises
to be a useful tool in investigating nuclear protein
synthesis.
When nuclear proteins were separated into a
fraction soluble in 0.15 M NaCl and a residual
fraction, the specific activity of both fractions
was found to decrease proportionally upon puro-
mycin treatment. This observation is compatible
with the hypothesis that puromycin exerts its
differential effect by a greater over-all inhibition
of cytoplasmic as compared with nuclear protein
synthesis rather than by a selective inhibition of
the synthesis of certain proteins . Further data
will be required to decide this question, however .
Taken as a whole, the data support the view
that the synthesis of proteins in the nucleus pro-
ceeds by a mechanism which is similar, if not
identical, to the mechanism predominating in
the cytoplasm. The differential effect of puromycin
at the two sites does not necessarily indicate a
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TABLE I
Effect of Inhibitors on Nuclear and Cytoplasmic Protein Synthesis
Experimental design is described under Materials and Methods . Most values were
obtained from a single determination ; where more than one determination was made,
the values presented are the averages . The figures beneath each inhibitor indicate the
dosage and time between injection of the inhibitor and injection of the labeled amino
acid.
* Animals were injected with 50 mg/kg of thioacetamide every day for 8 days ; labeled
amino acid was given 1 day after the final injection of drug .
difference in the protein-synthesizing systems,
but might result from some unrelated factor such
as a differential rate of uptake of puromycin by
the nucleus and the cytoplasm.
The failure of chloramphenicol to inhibit
nuclear protein synthesis and the pronounced
inhibition caused by even low concentrations of
cycloheximide are in marked contrast to the
results obtained with mitochondria and chloro-
plasts. Chloramphenicol has been shown to
inhibit protein synthesis in mitochondria, chloro-
plasts, and bacteria, but not in microsomal sys-
tems (2, 4, 6), whereas cycloheximide is known
to inhibit protein formation in microsomal sys-
tems but not in mitochondria or bacteria and
probably not in chloroplasts (2, 6) . Thus, the
Disintegrations/min per mg protein
Treatment Cytoplasm Nucleus Cytoplasm/Nucleus
Control 7010 4170 1 .68
Actinomycin D
2 mg/kg-4 hr 8090 5000 1 .62
Actinomycin D
2 mg/kg-16 hr 1530 1160 1 .32
Control 12070 9160 1 .32
Chloramphenicol
30 mg/kg-5 min 19370 12870 1 .50
Chloramphenicol
30 mg/kg-70 min 28200 19560 1 .44
Control 10100 7930 1 .28 f 0 .22
Streptomycin
50 mg/kg-5 min 18600 14400 1 .29
Streptomycin
50 mg/kg-70 min 15000 10000 1 .50
Cycloheximide
0 .25 mg/kg-5 min 2150 1490 1 .44
Cycloheximide
1 .00 mg/kg-5 min 651 461 1 .41
Puromycin
25 mg/kg-5 min 2750 3160 0 .87
Puromycin
25 mg/kg-20 min 1900 2470 0.77 ± 0 .10
Puromycin
75 mg/kg-20 min 511 681 0 .75
Thioacetamide
50 mg/kg-50 min 10300 9840 1 .05
Thioacetamide
50 mg/kg-23 hr 13500 9860 1 .37
Thioacetamide
8 X 50 mg/kg* 16600 11700 1 .42protein-synthesizing system in the cell nucleus
differs from that found in chloroplasts or in
mitochondria.
Chromatin-catalyzed amino acid incorporation
is inhibited by chloramphenicol (12) . The finding
that nuclear protein synthesis in vivo is not de-
pressed by this antibiotic indicates that the
chromatin system, if not an artifact, plays a
quantitatively minor role in nuclear protein
synthesis in vivo.
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